MPT Resource Center

Expanding the pipeline for multipurpose prevention technologies: compounds with potential activity to prevent or treat HIV and other STIs

HIV prevention: better choice for better coverage

Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention

Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs

Giving Voice to the End-User: Input on Multipurpose Prevention Technologies From the Perspectives of Young Women in Kenya and South Africa

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe

Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial

Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria

Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria December 2020 click to view Guidance Document In this Technical Brief: Topic(s): Contraceptive Products Special Import Permits Region(s): Zambia Nigeria

HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: Strategic insights from key stakeholders

Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women

Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products

Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis

Pre-exposure prophylaxis 2.0: New drugs and technologies in the pipeline

Efficacy is not everything: Eliciting women’s preferences for a vaginal HIV prevention product using a discrete-choice experiment

Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy

Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya

Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial

Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa

Population and the Environment — Time for Another Contraception Revolution

Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers

Topical inserts: A versatile delivery form for HIV prevention

The role of antimicrobial peptides in the prevention of sexually transmitted infection (STI)

End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: The Quatro clinical crossover study

A qualitative systematic review of women’s experiences using contraceptive vaginal rings: Implications for new technologies

G1-S4 or G2-S16 carbosilane dendrimer in combination with Platycodin D as a promising vaginal microbicide candidate with contraceptive activity

Two birds with one stone: Health care providers’ perspectives about prevention technologies in Kenya and South Africa

Acceptability of the woman’s condom in a phase III multicenter open-label study

Acceptability and predictors of uptake of anti-retroviral pre-exposure prophylaxis (PrEP) among fishing communities in Uganda: A cross-sectional discrete choice experiment survey

Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES

“We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study

Young women’s stated preferences for biomedical HIV prevention results of a discrete choice experiment in Kenya and South Africa

Preferred product attributes of potential multipurpose prevention technologies for unintended pregnancy and sexually transmitted infections or HIV among U.S. women

Perceptions of the “Fabric” – An exploratory study of a novel multi-purpose technology among women in Sub Saharan Africa

Long-acting technologies for infectious diseases in LMICs

Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories

Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo

A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV

Dual HIV and pregnancy prevention cost effective?

Effectiveness of female condom in preventing HIV and sexually transmitted infections: a systematic review protocol

Effectiveness of female condom in preventing HIV and sexually transmitted infections: a systematic review protocol 07 August 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Topic(s): Product Introduction / Uptake Reproductive Health Social/Behavioral Context

Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women

Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women 23 July 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Trials Region(s): Africa

Solid state 13C NMR spectroscopy provides direct evidence for reaction between ethinyl estradiol and a silicone elastomer vaginal ring drug delivery system

Solid state 13C NMR spectroscopy provides direct evidence for reaction between ethinyl estradiol and a silicone elastomer vaginal ring drug delivery system 14 July 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Development

Technoeconomic modeling of plant-based Griffithsin manufacturing

Technoeconomic modeling of plant-based Griffithsin manufacturing 02 July 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Product Type(s): Microbicides Topic(s): Product Development Region(s): United States

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women 28 June 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): MPTs Product Trials

Development of a vaginal fast-dissolving insert combining Griffithsin and Carrageenan for potential use against sexually transmitted infections

Development of a vaginal fast-dissolving insert combining Griffithsin and Carrageenan for potential use against sexually transmitted infections 11 June 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV HPV Product Type(s): Other or N/A Topic(s): MPTs Product Development

Contraceptive method use and chlamydia positivity among California Family Planning Clients: The case for new multipurpose prevention technologies

Contraceptive method use and chlamydia positivity among California Family Planning Clients: The case for new multipurpose prevention technologies 01 June 2018 click to view Journal Article In this Journal Article: Health Risk(s): Chlamydia Product Type(s): Hormonal Contraceptives Topic(s): Reproductive Health Region(s): United States